Lydia Nakopoulou - Concepedia

Author

Lydia Nakopoulou

National and Kapodistrian University of Athens

Also Known As

L Nakopoulou, L. Nakopoulou, LYDIA NAKOPOULOU, Lydia N. Caro, Lydia Nakopoulou, Nakopoulou Lydia

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Alexandra Hospital Athens State University Laiko General Hospital of Athens Evangelismos Hospital

About

Lydia Nakopoulou is an author at National and Kapodistrian University of Athens specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	1.1K
2	Cell Biology	7	7	509
3	Health Sciences	1	1	66
4	Anatomy	1	1	10
5	Gastroenterology	1	1	10

Lydia Nakopoulou

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease Konstantinos Kambas, Akrivi Chrysanthopoulou, Dimitrios Vassilopoulos, Annals of the Rheumatic Diseases	2013	254
The clinicopathologic and prognostic significance of CD44+/CD24−/low and CD44−/CD24+ tumor cells in invasive breast carcinomas Eleni Mylona, Ioanna Giannopoulou, Emmanouil Fasomytakis, Human Pathology Tumor BiologyBreast OncologyOncologyMedicinePathology	2008	148
The prevalence of bcl-2, p53, and ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates Lydia Nakopoulou, Christina Vourlakou, Anastasios Zervas, Human Pathology UrologyGenitourinary CancerMalignant DiseaseMedicinePathology	1998	130
MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival Lydia Nakopoulou, Ioanna Tsirmpa, Paraskevi Alexandrou, Breast Cancer Research and Treatment Breast OncologyOncologyOverall SurvivalMedicineMmp-2 Protein	2003	113
The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin Kostas Stylianou, Ioannis Petrakis, Vasiliki Mavroeidi, Nephrology Dialysis Transplantation	2010	111
Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: Correlation with proliferation Lydia Nakopoulou, Kalliopi Stefanaki, Effie Panayotopoulou, Human Pathology Breast OncologyAngiogenesisMedicineCancer GrowthPathology	2002	106
Enhanced mRNA expression of tissue inhibitor of metalloproteinase‐1 (TIMP‐1) in breast carcinomas is correlated with adverse prognosis Lydia Nakopoulou, Ioanna Giannopoulou, Kalliopi Stefanaki, The Journal of Pathology	2002	90
Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas Christina Μagkou, Lydia Nakopoulou, Christina Zoubouli, Breast Cancer Research	2008	88
Matrix metalloproteinase-1 and -3 in breast cancer: Correlation with progesterone receptors and other clinicopathologic features Lydia Nakopoulou, Ioanna Giannopoulou, Hariklia Gakiopoulou, Human Pathology Breast OncologyProgesterone ReceptorsMedicineMetalloproteinMatrix Metalloproteinase-1	1999	81
Heat shock protein 70 and HLA-DR molecules tissue expression Andreas C. Lazaris, George Theodoropoulos, Panayotis S. Davaris, Diseases of the Colon & Rectum	1995	77

Page 1